(Top) NO formation and intracellular cyclic GMP in platelets from controls and uremic patients. (Bottom) NO formation by human endothelial cells (HUVEC) exposed to control or uremic plasma. *P < .01 versus controls. (Modified and reprinted with permission from Noris et al.48,57)